Waldron Private Wealth LLC Dexcom Inc Transaction History

Waldron Private Wealth LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$114.22 - $140.1 $182,980 - $224,440	1,602 New	1,602 $222,000
Q2 2023 Aug 29, 2024	SELL	$112.47 - $130.98 $141,712 - $165,034	-1,260 Reduced 44.07%	1,599 $205,000
Q2 2023 Aug 07, 2023	SELL	$112.47 - $130.98 $141,712 - $165,034	-1,260 Reduced 44.07%	1,599 $205,000
Q1 2023 Aug 29, 2024	BUY	$104.0 - $122.92 $297,336 - $351,428	2,859 New	2,859 $332,000
Q1 2023 May 02, 2023	BUY	$104.0 - $122.92 $2,704 - $3,195	26 Added 0.92%	2,859 $332,000
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $216,299 - $266,811	2,833 New	2,833 $228,000
Q2 2022 Aug 03, 2022	SELL	$67.99 - $132.89 $35,150 - $68,704	-517 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$94.08 - $130.2 $4,986 - $6,900	53 Added 11.42%	517 $264,000
Q4 2021 Feb 02, 2022	BUY	$129.87 - $162.82 $779 - $976	6 Added 1.31%	464 $249,000
Q3 2021 Nov 02, 2021	BUY	$106.71 - $143.18 $48,873 - $65,576	458 New	458 $250,000
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $62,559 - $73,982	-655 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$62.68 - $105.34 $41,055 - $68,997	655 New	655 $265,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Waldron Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Waldron Private Wealth LLC with notifications on news.